NEW YORK, Feb. 27, 2017 /PRNewswire-USNewswire/ -- Sheldon M. Feldman, M.D., has been
Dr. Feldman is known for spearheading the use of cutting edge therapies so women and men can fight cancer with minimal treatment and side effects. He has pioneered techniques such as intraoperative radiation, which involves administering a single dose of radiation during surgery, enabling most patients to avoid additional radiation. An internationally renowned breast surgeon, Dr. Feldman is also an innovator in reducing risk of lymphedema, a permanent swelling of the arms that can result from breast cancer treatment.
"Dr. Feldman has a long-standing history of providing exceptional patient care," said Robert E. Michler, M.D., professor and chairman of the department of surgery, professor and chairman of cardiothoracic & vascular surgery, Samuel I. Belkin Endowed Chair, Montefiore and Einstein. "His surgical skill, compassion for his patients, and leadership in developing new approaches to the surgical management of breast cancer will be an important addition to our center and serve as a fine example for educating the next generation of surgeons."
Dr. Feldman is the president of the American Society of Breast Surgeons, the nation's leading organization for treating patients with breast disease and advocacy for surgeons who seek excellence in the care of breast patients.
Dr. Sheldon Feldman will lead the breast surgery and breast surgical oncology program at Montefiore and Einstein after a long and successful career as Chief of the Breast Surgery Division at NewYork-Presbyterian Hospital / Columbia University Medical Center and as the Vivian L. Milstein Associate Professor of Clinical Surgery. Dr. Feldman will serve as a principle investigator on multiple breast cancer studies focused on advancing prevention, early diagnosis and patient centered treatment of the disease.
With a deep commitment to social medicine, Dr. Feldman will lead Montefiore system-wide efforts across the Bronx, Westchester and Hudson Valley to advance cancer care research and patient experiences. Since 2003, he has been recognized annually as one of New York Metro Area's Top Doctors and since 2004, he has also been included in the annual "Guide to America's Top Surgeons."
"We are thrilled to have Dr. Feldman join our Breast Cancer Program, which recently retained its status by the National Accreditation Program for Breast Centers, as having the highest care standards for treating people with breast disease," said Joseph Sparano, M.D., Chief of the Section of Breast Medical Oncology at Montefiore, and Associate Director for Clinical Research at the Albert Einstein Cancer Center.
"Dr. Feldman's pioneering role in designing new techniques for breast cancer treatment, and his research into prevention, complements our team's personalized care approach and status as a leading international center for breast cancer research."
Dr. Feldman's move to Montefiore and Einstein brings innovative clinical trials focused on advancing minimally invasive or non surgical approaches to threatening breast cancer. The trials will now be conducted at Montefiore Einstein Center for Cancer Care, under the auspices of the NCI-designated Albert Einstein Cancer Center. He is also an expert in skin-sparing and nipple-preserving mastectomies.
A native New Yorker, Dr. Feldman was born in Brooklyn and graduated from Stuyvesant High School and State University at Stony Brook. He earned his medical degree, and completed his surgical training at New York University School of Medicine before a clinical fellowship in peripheral vascular surgery at Newark Beth Israel Medical Center.
About Montefiore Health System Montefiore Health System is one of New York's premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children's Hospital at Montefiore, Burke Rehabilitation Hospital and close to 200 outpatient care sites. The advanced clinical and translational research at its' medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its' preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.
About Albert Einstein College of Medicine Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation. During the 2016-2017 academic year, Einstein is home to 717 M.D. students, 166 Ph.D. students, 103 students in the combined M.D./Ph.D. program, and 278 postdoctoral research fellows. The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its clinical affiliates. In 2016, Einstein received more than $160 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sheldon-m-feldman-md-named-chief-division-of-breast-surgery--surgical-oncology-and-director-of-breast-cancer-services-at-montefiore-and-einstein-300413944.html
SOURCE Montefiore Medical Center
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All